P19 Response to second-line protease-inhibitor (PI) regimens: results from the EuroSIDA study

Autor:	A Mocroft, An Phillips, V Miller, J Gatell, J van Lunzen, A Lazzarin, Jd Lundgren on, behalf of, the EuroSida Study Group
Rok vydání:	2000
Předmět:	Infectious Diseases Second line business.industry Health Policy Pi medicine Pharmacology (medical) Pharmacology business Protease inhibitor (biology) medicine.drug
Zdroj:	HIV Medicine. 1:178-179
ISSN:	1468-1293 1464-2662
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4ac7f9481ec8a206d839ba3dd9f29448 https://doi.org/10.1046/j.1468-1293.2000.00024-85.x Zobrazit plný text záznamu Plný text ve formátu PDF